$2.03 Billion is the total value of Novo Holdings A/S's 54 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 31.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CTLT | Buy | CATALENT INC | $175,191,000 | +24.2% | 1,632,878 | +28.4% | 8.63% | +16.0% |
| SYK | New | STRYKER CORPORATION | $158,535,000 | – | 796,941 | +100.0% | 7.81% | – |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $130,773,000 | -14.8% | 3,508,788 | +1.3% | 6.44% | -20.4% |
| STE | New | STERIS PLC | $96,414,000 | – | 467,687 | +100.0% | 4.75% | – |
| CRM | Buy | SALESFORCE.COM, INC. | $78,972,000 | +24.4% | 478,500 | +60.0% | 3.89% | +16.1% |
| CORT | New | CORCEPT THERAPEUTICS INC | $60,080,000 | – | 2,526,490 | +100.0% | 2.96% | – |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $58,106,000 | +21.5% | 710,780 | +54.9% | 2.86% | +13.4% |
| CABO | Buy | CABLE ONE INC | $57,340,000 | +146.7% | 44,473 | +180.2% | 2.82% | +130.3% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $28,300,000 | +16.7% | 2,635,000 | +2.9% | 1.39% | +9.0% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $26,311,000 | – | 317,500 | +100.0% | 1.30% | – |
| PCVX | New | VAXCYTE INC | $17,924,000 | – | 823,705 | +100.0% | 0.88% | – |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $15,995,000 | +10.1% | 316,674 | +39.2% | 0.79% | +2.7% |
| INSM | Buy | INSMED INC | $15,184,000 | -8.5% | 770,000 | +9.1% | 0.75% | -14.5% |
| NARI | Buy | INARI MED INC | $14,278,000 | +27.9% | 210,000 | +70.6% | 0.70% | +19.4% |
| VERV | Buy | VERVE THERAPEUTICS INC | $14,166,000 | -17.2% | 927,100 | +23.6% | 0.70% | -22.7% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $12,368,000 | +203.0% | 84,800 | +239.2% | 0.61% | +183.3% |
| ABCL | New | ABCELLERA BIOLOGICS INC | $12,002,000 | – | 1,126,915 | +100.0% | 0.59% | – |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $11,780,000 | +26.3% | 631,627 | +48.7% | 0.58% | +17.9% |
| PHVS | Buy | PHARVARIS N V | $11,477,000 | +22.5% | 519,339 | +0.6% | 0.56% | +14.4% |
| INSP | Buy | INSPIRE MED SYS INC | $10,303,000 | -3.2% | 56,400 | +36.1% | 0.51% | -9.6% |
| KNTE | Buy | KINNATE BIOPHARMA INC | $10,286,000 | +46.3% | 815,707 | +30.7% | 0.51% | +36.7% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $8,708,000 | -10.4% | 632,822 | +3.3% | 0.43% | -16.4% |
| TMCI | Buy | TREACE MED CONCEPTS INC | $8,436,000 | -10.9% | 588,308 | +17.6% | 0.42% | -16.8% |
| LUNG | Buy | PULMONX CORP | $7,515,000 | -26.1% | 510,555 | +24.5% | 0.37% | -31.1% |
| Buy | RALLYBIO CORP | $4,870,000 | +60.0% | 645,021 | +48.0% | 0.24% | +49.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-05-10 |
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
| 4 | 2024-03-18 |
| SC 13D/A | 2024-03-18 |
| 144 | 2024-03-14 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.